e-Cultura: The second session of the 5th edition of “Tratar o cancro por tu” goes to Guarda
Guarda will host the second session of “Tratar o cancro por tu”.
Category 5th Edition
IARC [Twitter]
Dr Elisabete Weiderpass spoke during the 5th Season of the "Tratar o cancro por tu" series, which began in Matosinhos, Porto, Portugal.
Câmara Municipal de Matosinhos [Facebook]
The Constantino Nery Municipal Theatre in Matosinhos hosted yesterday the inaugural session of the 5th edition of the "Tratar o cancro por tu" initiative, promoted by Ipatimup.
Matosinhos City Council: Matosinhos hosted the inaugural session of the fifth edition of this Ipatimup initiative
The Constantino Nery Municipal Theatre in Matosinhos hosted yesterday the inaugural session of the fifth edition of the national initiative “Tratar o cancro por tu”, promoted by Ipatimup.
IARC [Linkedin]
Dr Elisabete Weiderpass spoke during the 5th Season of the “Tratar o cancro por tu” series, which began in Matosinhos, Porto, Portugal.
RTP: Jornal da Tarde
"Tratar o cancro por tu" - The disease is the second leading cause of death worldwide.
SIC Notícias: Cancer cases are expected to increase substantially: learn what you should do to prevent them
Cancer is the second leading cause of death worldwide after cardiovascular diseases. In 2022, cancer killed 10 million people.
Jornal de Notícias: Scientists and citizens return to open and honest conversations with “Tratar o cancro por tu”
The "Tratar o cancro por tu" initiative, organized by the Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), is back for its fifth edition.
Antena 1 [Facebook]
Five years after the start of the "Tratar o cancro por tu" initiative, Ipatimup is back "on the road" to once again talk about, raise awareness about, and share knowledge about cancer with the public.
Notícias Agora: Researcher Manuel Sobrinho Simões states that cancer can be controlled but there will be no vaccine.
Cancer will not have a single vaccine, but it is increasingly becoming a controllable chronic disease, with screening, prevention, and information being the focus.